Cargando…

Hormone Receptor Signaling and Breast Cancer Resistance to Anti-Tumor Immunity

Breast cancers regroup many heterogeneous diseases unevenly responding to currently available therapies. Approximately 70–80% of breast cancers express hormone (estrogen or progesterone) receptors. Patients with these hormone-dependent breast malignancies benefit from therapies targeting endocrine p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moisand, Alexandra, Madéry, Mathilde, Boyer, Thomas, Domblides, Charlotte, Blaye, Céline, Larmonier, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606577/ https://www.ncbi.nlm.nih.gov/pubmed/37894728 http://dx.doi.org/10.3390/ijms242015048

Ejemplares similares

Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers
por: Blaye, Céline, et al.
Publicado: (2022)

Influence of the Metabolism on Myeloid Cell Functions in Cancers: Clinical Perspectives
por: Boyer, Thomas, et al.
Publicado: (2022)

Editorial: Tumor-promoting immune cells: Cancer immune escape and beyond
por: Domblides, Charlotte, et al.
Publicado: (2023)

An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
por: Blaye, C., et al.
Publicado: (2022)

Control of the Antitumor Immune Response by Cancer Metabolism
por: Domblides, Charlotte, et al.
Publicado: (2019)

Metabolic Stress in the Immune Function of T Cells, Macrophages and Dendritic Cells
por: Domblides, Charlotte, et al.
Publicado: (2018)

Combinations of Anti-Angiogenic Agents and Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Best Option?
por: Granet-Vaissiere, Estelle, et al.
Publicado: (2023)

Interleukin-2/Anti-Interleukin-2 Immune Complex Expands Regulatory T Cells and Reduces Angiotensin II-Induced Aortic Stiffening
por: Majeed, Beenish, et al.
Publicado: (2014)

The Dendritic Cell-Regulatory T Lymphocyte Crosstalk Contributes to Tumor-Induced Tolerance
por: Janikashvili, Nona, et al.
Publicado: (2011)

Role of serotonin receptor signaling in cancer cells and anti-tumor immunity
por: Karmakar, Surojit, et al.
Publicado: (2021)

Adrenergic receptor signaling regulates the CD40-receptor mediated anti-tumor immunity
por: Singh, Akansha, et al.
Publicado: (2023)

Steroid Hormone Receptor Signals as Prognosticators for Urothelial Tumor
por: Ide, Hiroki, et al.
Publicado: (2015)

Triple Targeting of Breast Tumors Driven by Hormonal Receptors and HER2
por: Shagisultanova, Elena, et al.
Publicado: (2022)

Hormones, Receptors and Breast Cancer
por: Barnes, D. M.
Publicado: (1979)

Management of Immune Checkpoint Inhibitor Toxicities
por: Durrechou, Quentin, et al.
Publicado: (2020)

Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer
por: Vos, Hanne, et al.
Publicado: (2021)

Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses
por: Scarpitta, Allan, et al.
Publicado: (2021)

The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer
por: Privette Vinnedge, Lisa M., et al.
Publicado: (2012)

The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity
por: Schnell, Alexandra, et al.
Publicado: (2020)

Signal‐transducing innate receptors in tumor immunity
por: Hangai, Sho, et al.
Publicado: (2021)

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells
por: Gómez-Aleza, Clara, et al.
Publicado: (2020)

The Expression of Anti-Müllerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in Cancer
por: Barret, Jean-Marc, et al.
Publicado: (2021)

Cytotoxic and antigen presenting functions of T helper-1-activated dendritic cells
por: Larmonier, Nicolas, et al.
Publicado: (2012)

The Multifaceted Role of Th17 Lymphocytes and Their Associated Cytokines in Cancer
por: Alizadeh, Darya, et al.
Publicado: (2013)

Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014)

Editorial: Hormone Receptors and Breast Cancer
por: Brunetti, Antonio, et al.
Publicado: (2019)

Editorial: Hormones and receptors in breast cancer
por: Rosemblit, Cinthia, et al.
Publicado: (2023)

Haploid Embryogenesis in Isolated Microspore Culture of Carrots (Daucus carota L.)
por: Shmykova, Natalia, et al.
Publicado: (2020)

The roles of anti-Müllerian hormone in breast cancer
por: Chen, Xuan, et al.
Publicado: (2023)

Pharmacokinetics, distribution and anti-tumor efficacy of liposomal mitoxantrone modified with a luteinizing hormone-releasing hormone receptor-specific peptide
por: Zhang, Linhua, et al.
Publicado: (2018)

Parathyroid hormone 1 receptor signaling mediates breast cancer metastasis to bone in mice
por: Swami, Srilatha, et al.
Publicado: (2023)

New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma
por: Perez-Lanzon, Maria, et al.
Publicado: (2023)

The nuclear corepressor 1 and the thyroid hormone receptor β suppress breast tumor lymphangiogenesis
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2016)

The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
por: Yuan, Jie, et al.
Publicado: (2023)

Thyroid hormone and anti-apoptosis in tumor cells
por: Lin, Hung-Yun, et al.
Publicado: (2015)

Parity improves anti-tumor immunity in breast cancer patients
por: Krause, Anna-Lena, et al.
Publicado: (2017)

The impact of β-adrenergic signaling on radioresistance and anti-tumor immunity
por: Bucsek, Mark, et al.
Publicado: (2015)

Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer
por: Rene Gonzalez, Ruben, et al.
Publicado: (2009)

Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal Resistance
por: Manso, Luis, et al.
Publicado: (2016)

Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer
por: Griguolo, Gaia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_61tok0j524s2lf2jlel9a97vom